CAR T-Cell Therapy Feasible, Safe in Advanced Neuroblastoma ORR of 63% with GD2-targeting product in kids with relapsed, refractory high-risk disease Apr 06, 2023
Major Survival Gain With Immunotherapy in Lymphomatoid Granulomatosis Median overall survival reached 20 years with interferon alfa-2b in low-grade disease Apr 05, 2023
FDA Greenlights New First-Line Regimen in Bladder Cancer Enfortumab vedotin plus pembrolizumab approved for cisplatin-ineligible patients Apr 04, 2023
Obesity's Impact on Uterine Cancer Risk Greater in Younger Age Groups Overall risk and risk of endometrioid subtype 20- to 30-fold greater in women younger than 35 Mar 30, 2023
A 'Double Whammy' for Gastric Cancer Risk H. pylori infection and certain pathogenic variants linked with large excess risk Mar 29, 2023
Phase III Trials 'Hit a Home Run' in Advanced Endometrial Cancer Adding immunotherapy will change frontline treatment, experts say Mar 28, 2023
No Survival Benefit With CRT Versus Chemo for Locally Advanced Endometrial Cancer Long-running clinical trial failed to identify any subgroup that fared better with CRT Mar 27, 2023
CRT Regimen Boosts Complete Response Rate in Unresectable Vulvar Cancer Pathologic response rises to 73% versus 50% in historical control group Mar 27, 2023
Cancer Transmission From Organ Donors With Brain Tumors Not Much of a Risk In U.K. cohort study, no cases of transmission observed Mar 22, 2023
Laparoscopy, Surgery in a Draw for Gastric Cancer Survival Laparoscopy-assisted distal gastrectomy noninferior for both relapse-free, overall survival Mar 15, 2023
A Space for Mystery Elisha Waldman, MD, discusses faith and spirituality in medicine Mar 07, 2023 podcast
These Surgeries Made the Sharpest Turns to Outpatient Setting After COVID Several procedures saw significant increases in outpatient volumes Mar 03, 2023
'Winners' and 'Losers'; Mandated Sick Leave and Cancer Screening; More AI Advances News, features, and commentary about cancer-related issues Mar 03, 2023
Cancer-Free Medicare Recipients Received Fentanyl Indicated for Cancer Pain These prescriptions could lead to abuse, OIG report warns Mar 02, 2023
Cancer Drugs That Didn't Work; Another HIV Cure; Kiss of Success With Mistletoe News, features, and commentary about cancer-related issues Feb 24, 2023
Pembrolizumab Active in BCG-Unresponsive Papillary High-Risk Bladder Cancer KEYNOTE-057 trial results suggest DFS benefit for patient population with unmet need Feb 19, 2023
The 'Extreme' Story of How Two Game-Changing Cancer Drugs Came to Market New book by former Forbes senior editor pulls back the curtain on drug development Feb 13, 2023
Biden Pledges to Extend Medicare's Solvency for 'At Least Two Decades' Healthcare featured prominently in president's State of the Union address Feb 08, 2023
MDM2 Inhibitor Breaks Through in Trial of Liposarcoma, Other Advanced Malignancies Intermittent dosing dramatically reduced myelosuppression that has hindered drug class Jan 26, 2023
What Caused a Man to Develop Friable Bleeding Nodules on His Arms and Hips? The cause lies in a lengthy history of cancer treatment, confirmed by histopathology analysis Jan 23, 2023
'More Is Not Better' in Two First-Line Trials for Biliary Tract Cancer No survival benefit with three-drug chemo regimen or clear PFS gain with anti-PD-L1/bevacizumab Jan 22, 2023
New First-Line Standard for Metastatic Pancreatic Cancer Liposomal irinotecan regimen boosts outcomes, although expert expressed concern about toxicity Jan 22, 2023
Adding Targeted Drug to Chemo Boosts Survival in Gastric/GEJ Cancer Longest overall survival reported to date with the addition of zolbetuximab to chemotherapy Jan 21, 2023
Perioperative Chemo Matches Multimodal Tx for Locally Advanced Esophageal/GEJ Cancer Nearly identical 3-year survival, questioning the need for radiotherapy before surgery Jan 20, 2023
The Unfulfilled Promise of Cannabis for Cancer-Related Symptoms Medical cannabis is currently too far removed from the standards of medical practice Jan 14, 2023
For People With HIV, Early Anal Cancer Screening Tied to Better Outcomes All people with HIV should be screened, not just men who have sex with men, researchers say Jan 13, 2023
MRI-Guided Focused Ultrasound Eases Pain From Bone Metastases More responses with ultrasound, but quality-of-life scores lower vs EBRT in nonrandomized trial Jan 11, 2023
Study Supports Routine Omentectomy in Absence of Metastasis During CRS-HIPEC High rate of occult metastases in patients with grossly normal omentum Jan 11, 2023
Bariatric Surgery May Reduce Risk of Esophageal, Gastric Cancers Cohort study provides "reassurance of the protective clinical benefits of weight loss surgery" Jan 11, 2023
Conspiracy Theorists' Cancer Beliefs; HIV Meds and Ethnicity Also in TTHealthWatch: sodium levels and health outcomes Jan 07, 2023 podcast
More Evidence to Support Restrictive Opioid Prescribing After Cancer Surgery Significant decreases in prescription days, doses, refill requests, with few patient complaints Jan 06, 2023
Watch for New Psych Disorders in the Spouses of Cancer Patients Risk especially high within the first year after cancer diagnosis Jan 05, 2023
Jazz Musician With Slowly Expanding Neck Mass Causing Dysphagia Alcoholism, liver dysfunction highly linked with rare disease of unknown etiology Jan 04, 2023
Can Dying Well Be a Part of Living Well? Shoshana Ungerleider, MD, on her mission to transform end-of-life care Jan 03, 2023 podcast
FDA Approves First Gene Therapy for Non-Muscle-Invasive Bladder Cancer Half of patients achieved complete responses with adenoviral vector-based product Dec 16, 2022
No Blaming Common Antihypertensives for Pancreatic Cancer, Study Suggests Some reassurance on widely prescribed dihydropyridine calcium channel blockers Dec 15, 2022
Direct-Acting Antivirals Linked to Improved Outcomes in Chronic Hepatitis C All-cause mortality rate significantly lower in treated versus untreated group Dec 13, 2022
Pharmacogenomic Results Clear to Young Cancer Patients' Families But few guardians shared these results with other care providers Dec 09, 2022
Small Study Shows Most Crohn's Patients With Anal Cancer Survived 15 of 24 were alive and cancer free at 5.5 years of follow-up Dec 09, 2022
